SSH Notice - HGH (ICT Investments) Limited

Posted by Default Admin on 2 March 2015

SSH Notice - HGH (ICT Investments) Limited

8:30am, 2 Mar 2015 | SSH

DISCLOSURE OF MOVEMENT OF 1% OR MORE IN SUBSTANTIAL HOLDING OR CHANGE IN NATURE OF RELEVANT INTEREST, OR BOTH

Sections 277 and 278, Financial Markets Conduct Act 2013

TO: NZX Limited 
and 
TO: Finzsoft Solutions Limited ("FIN")

Relevant event being disclosed: Change in nature of relevant interest

Date of relevant event: 1 March 2015

Date this disclosure made: 1 March 2015

Date last disclosure made: 18 December 2014

Substantial product holder giving disclosure

Full name(s): Holliday Group Holdings (ICT Investments) Limited ("HGH")

Summary of previous substantial holding

Class of quoted voting products: Ordinary shares 
Summary for: HGH 
For this disclosure: 
(a) total number held in class: 5,646,438 
(b) total in class: 8,566,163 
(c) total percentage held in class: 65.916%

For last disclosure: 
(a) total number held in class: 5,646,438 
(b) total in class: 8,566,163 
(c) total percentage held in class: 65.916%


Details of transactions and events giving rise to relevant event

Details of the transactions or other events requiring disclosure: On 27 February 2015, Silverlake HGH Limited made a full takeover offer under the Takeovers Code to acquire all the equity securities in FIN ("Offer"). A copy of the Offer document was sent to NZX by Silverlake HGH Limited on 27 February 2015.

On 1 March 2015, HGH, who entered into the lock-up agreement referred to in the substantial product holder notice filed by HGH on 18 December 2014, accepted the Offer for its holding of 5,646,438 shares in FIN in accordance with the terms of that lock-up agreement. The consideration payable under the Offer for the shares in FIN held by HGH is $16,939,314.

Details after relevant event

Details for: HGH 
Nature of relevant interest(s): Registered holder and beneficial owner of financial products conditional upon payment of the relevant consideration for the financial products under the Offer. 
For that relevant interest: 
(a) number held in class: 5,646,438 
(b) percentage held in class: 65.916% 
(c) current registered holder(s): HGH 
(d) registered holder(s) once transfers are registered: Silverlake HGH Limited 
Additional information

Address(es) of substantial product holder(s): 22 Winscombe Street, Belmont, Auckland, 0622 
Contact details: Andrew Holliday 
Phone: +64 21 355 492 
Email: Andrew.Holliday@finzsoft.com 
Name of any other person believed to have given, or believed to be required to give, a disclosure under the Financial Markets Conduct Act 2013 in relation to the financial products to which this disclosure relates: Silverlake HGH Limited.

Certification 
I, Andrew Alexander Holliday, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

Download PDF